Bal Pharma Current Share Price | Bal Pharma Stock Screener
BALPHARMA
Pharmaceuticals
Bal Pharma Current Stock Price Today
Live Share Price NSE
₹100.67
▼
-1.79 (-1.75%)
Live Share Price BSE
₹100.27
▼
-1.77 (-1.73%)
As of September 18, 2026, the live Bal Pharma share price (NSE: BALPHARMA) is ₹100.67 on NSE and ₹100.27 on BSE, down 1.75% from the previous close, with shares trading between ₹100.10 and ₹103.94 in today's trading session, and a 52-week range of ₹60.42–₹114.45.
Browse BALPHARMA income statement to support your investment research.
Use the Bal Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bal Pharma Market Cap
₹171.02 Cr.
BALPHARMA P/E Ratio (TTM)
23.37
Bal Pharma P/B Ratio
2.06
EPS (TTM)
₹3.95
Dividend Yield
1.13%
Debt to Equity
1.94
BALPHARMA 52 Week High
₹114.45
Bal Pharma 52 Week Low
₹60.42
Operating Margin
13.00%
Profit Margin
4.76%
BALPHARMA Revenue (TTM)
₹84.00
EBITDA
₹10.00
Net Income
₹4.00
Total Assets
₹376.00
Total Equity
₹82.00
Bal Pharma Current Share Price Chart
Track the current Bal Pharma share price and stock price with an interactive chart. Analyse BALPHARMA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Bal Pharma stock quote in one place.
Bal Pharma Company Profile - Fundamental Screener
Screen Bal Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BALPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083D01012
Bal Pharma Balance Sheet Screener
Screen BALPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 376 | 336 | 320 | 313 | 261 | 240 | 238 | 261 | 260 | 233 |
| Current Assets | 262 | 235 | 234 | 228 | 185 | 164 | 157 | 183 | 185 | 165 |
| Fixed Assets | 98 | 87 | 80 | 77 | 67 | 69 | 71 | 70 | 72 | 60 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 44 | 39 | 45 | 40 | 36 | 34 | 34 | 38 | 46 | 30 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 82 | 77 | 72 | 64 | 59 | 53 | 45 | 60 | 60 | 60 |
| Share Capital | 16 | 16 | 16 | 16 | 15 | 15 | 14 | 14 | 14 | 14 |
| Reserves & Surplus | 66 | 62 | 56 | 48 | 43 | 38 | 38 | 53 | 51 | 48 |
Bal Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Bal Pharma income statement and profit fundamentals.
Analyze BALPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bal Pharma share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84 | 89 | 83 | 67 | 75 | 88 | 97 | 75 | 74 | 74 | 83 | 71 | 93 | 82 | 78 |
| Expenses | 74 | 81 | 74 | 60 | 68 | 78 | 85 | 68 | 66 | 65 | 74 | 64 | 85 | 74 | 71 |
| EBITDA | 10 | 8 | 9 | 7 | 7 | 10 | 12 | 7 | 8 | 8 | 8 | 7 | 8 | 8 | 7 |
| Operating Profit % | 13.00% | 9.00% | 9.00% | 9.00% | 8.00% | 11.00% | 10.00% | 9.00% | 10.00% | 11.00% | 10.00% | 9.00% | 8.00% | 10.00% | 5.00% |
| Depreciation | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 2 | 3 | 2 |
| Interest | 4 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 3 |
| Profit Before Tax | 3 | 1 | 3 | 0 | 1 | 2 | 6 | 1 | 1 | 1 | 2 | 0 | 2 | 1 | 2 |
| Tax | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| Net Profit | 4 | 1 | 5 | 0 | 1 | 2 | 6 | 0 | 1 | 1 | 2 | 0 | 1 | 1 | 2 |
| EPS | 2.26 | 0.71 | 3.40 | 0.13 | 0.45 | 1.12 | 3.73 | 0.16 | 0.65 | 0.33 | 1.03 | 0.06 | 0.62 | 0.54 | 1.33 |
Bal Pharma Cash Flow Screener - Liquidity Fundamentals
Screen BALPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 23 | -2 | 27 | 22 | 23 | 8 | 1 | 6 | -19 |
| Investing Activities | -15 | -19 | -22 | -10 | -6 | -5 | -8 | -4 | -8 | -14 |
| Financing Activities | -8 | -1 | 24 | -17 | -17 | -20 | 0 | 4 | -6 | 32 |
| Net Cash Flow | -2 | 3 | 0 | 0 | 0 | -2 | 0 | 1 | -8 | -1 |
Bal Pharma Shareholding Pattern Screener
See Bal Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Bal Pharma promoter holding and ownership changes for BALPHARMA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.86% | 50.86% | 50.86% | 50.86% | 50.86% | 50.86% | 51.23% | 51.23% |
| FII Holding | 0.14% | 0.15% | 0.14% | 0.15% | 0.22% | 0.14% | 0.13% | 0.13% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.84% | 32.86% | 32.49% | 32.41% | 32.97% | 33.02% | 32.15% | 32.36% |
| Other Holding | 16.16% | 16.13% | 16.51% | 16.58% | 15.94% | 15.99% | 16.49% | 16.28% |
| Shareholder Count | 15,214 | 14,974 | 15,723 | 15,826 | 15,774 | 15,520 | 14,772 | 15,014 |
Bal Pharma Share Dividend Screener - Share Yield Analysis
Check Bal Pharma dividend history with payout and yield data.
View Bal Pharma dividend details including ex-dates and amounts for BALPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.20 | 1.99% |
| 2024-March | ₹1.20 | 1.43% |
| 2023-March | ₹1.00 | 1.10% |
| 2022-March | ₹1.00 | 1.55% |
| 2021-March | ₹1.00 | 0.93% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 3.13% |
| 2018-March | ₹1.00 | 1.43% |
| 2017-March | ₹1.00 | 1.30% |
Bal Pharma Stock Index Membership
See which indices include Bal Pharma stock.
Check BALPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bal Pharma Market Events Screener - Corporate Actions
Get Bal Pharma corporate actions including splits, bonuses, and buybacks.
Check Bal Pharma stock events that may affect BALPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 26.11% |
| 2026-09-17 | 2026-09-17 | Dividend | ₹ 1.20 /share | 16.00% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -1.26% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 16.20% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 4.74% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.77% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -9.49% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 1.20 /share | -6.50% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -3.59% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -6.14% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.22% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.93% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | 14.26% |
| 2024-09-17 | 2024-09-19 | Dividend | ₹ 1.20 /share | 31.47% |
| 2023-12-21 | 2023-12-21 | Extraordinary General Meeting | NA | -10.17% |
Bal Pharma Competitors Screener - Peer Comparison
Screen BALPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Bal Pharma Company Announcements - News Screener
Screen BALPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-16 | Clarification Regarding Movement In Price | - |
| 2026-09-16 | Clarification sought from Bal Pharma Ltd | - |
| 2026-09-13 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-27 | Intimation Of Record Date For Final Dividend | - |
| 2026-08-26 | Reg. 34 (1) Annual Report. | - |
| 2026-08-26 | Bal Pharma Limited - Notice Of AGM | - |
| 2026-08-26 | Intimation - 39Th AGM Scheduled On 24Th September 2026 | - |
| 2026-08-25 | Clarification With Respect To Tentative Timeline For Utilization Of Net Proceeds Of Preferential Issue | - |
| 2026-08-13 | Newspaper Publications - Unaudited Financial Results 30Th June 2026 And IEPF Notice | - |
| 2026-08-12 | Financial Result For The Quarter End 30Th June 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 12 2026 | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-05 | Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters | - |
| 2026-07-30 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 : Intimation Regarding Notice Of Postal Ballot | - |
| 2026-07-23 | Intimation Regarding Corrigendum To The Postal Ballot Notice | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-09 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-06-24 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-06-24 | Closure of Trading Window | - |